Welcome to the EF-CLIF web-page, the main working tool of our investigators. All protocols of the multicenter prospective observational studies and randomized controlled trials performed by our network of Hospitals and their clinical research forms are loaded in the reserved research area of the webpage. You will find in other areas detailed information related to the organization, rules, steering committees, research facilities and scientific production as well as the past and the future educational activities of the EF CLIF.
Among the participants, there were most Steering Committee Members of the EASL-CLIF Consortium, a selected group of investigators from the PREDICT Study, the Principal Investigators of the 2018 research program of the EF Clif, members of the Grifols Chair, Dr Tom Henning Karlsen, EASL General Secretary, Professors Roger Williams and Flair CarrilhoREAD MORE
His four-days stage at the EF Clif headquarters served to start coordinating efforts in the ACLARA Study preparation, following the plan designed at the PI's meeting held in Sao Paulo last September.READ MORE
The incorporation for both candidates is foreseen during the first quarter of 2018READ MORE
The Aclara Study aims to characterize the mechanisms of ACLF in Latin America and compare its results with the data obtained from other previous similar studies. The Aclara Study is a big challenge for both the EF Clif and the centres participating in this ambitious project, due to the complexity of the study and the amount of data to be managed.READ MORE
The CANONIC study has shown that among patients with acute decompensation (AD) of cirrhosis, those who had Acute-on-Chronic Liver Failure (ACLF, characterized by intense systemic inflammation, organ failures and poor outcome) were clearly distinct from those with traditional AD (who do not have organ failures and have good outcome).READ MORE
In both meetings, a general overview was presented on all the activities done during the previous year, and we also had a special focus on the development of the EF Clif and the enlargement of the CLIF Consortium hospital network (100 hospitals). In addition, we spent some time in presenting new projects and ideas, in both clinical and translational research, to be developed in the short and mid-term.READ MORE